Stansberry Research

U.S. Late-Day Stock Moves: CERE, EPAC, TWOU, MLHR, FOXA

Daniel SmootStansberry NewsWire

Advances:

  • Cerevel Therapeutics (CERE) +124.2%. CERE said its Phase I-B study for its schizophrenia treatment yielded positive results.
  • Enerpac Tool (EPAC) +6.8%. EPAC's third-quarter results beat estimates.
  • 2U (TWOU) +4.2%. TWOU will acquire edX's assets for $800 million.

Declines:

  • Herman Miller (MLHR) -6.8%. MLHR's fourth-quarter backlog disappointed.
  • Fox (FOXA) -3.5%. FOXA shares were downgraded from "buy" to "neutral" at Guggenheim.